Types of antidepressants
Pro Research Analysisby 
Searched over 200M research papers
Types of Antidepressants: An Overview
Introduction to Antidepressants
Antidepressants are medications used to treat major depressive disorder (MDD) and other conditions, including anxiety disorders, chronic pain, and some hormone-related disorders. They work by altering the balance of certain chemicals in the brain, known as neurotransmitters, which affect mood and emotions.
Classical Antidepressants: TCAs and MAOIs
Tricyclic Antidepressants (TCAs)
Tricyclic antidepressants (TCAs) are among the earliest forms of antidepressants. They work by blocking the reuptake of serotonin and norepinephrine, increasing the levels of these neurotransmitters in the brain. However, TCAs are associated with a higher incidence of side effects, such as dry mouth, blurred vision, and urinary retention, due to their antimuscarinic properties . They are less commonly used today due to these side effects and the availability of newer antidepressants .
Monoamine Oxidase Inhibitors (MAOIs)
Monoamine oxidase inhibitors (MAOIs) work by inhibiting the activity of monoamine oxidase, an enzyme that breaks down neurotransmitters like serotonin, norepinephrine, and dopamine. While effective, MAOIs can have severe dietary and drug interactions, making them less favorable compared to other antidepressants .
Selective Serotonin Reuptake Inhibitors (SSRIs)
SSRIs are the most commonly prescribed antidepressants. They work by selectively inhibiting the reuptake of serotonin, increasing its availability in the brain. Common SSRIs include fluoxetine, paroxetine, escitalopram, sertraline, and fluvoxamine . SSRIs are generally well-tolerated, but their efficacy can vary, with 30-40% of patients not showing a significant response .
New-Generation Antidepressants
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
SNRIs, such as venlafaxine and duloxetine, inhibit the reuptake of both serotonin and norepinephrine. They are often used when SSRIs are not effective and have shown comparable clinical results with different tolerability and safety profiles Mandrioli2017Yuan2020.
Serotonin Modulators and Stimulators (SMSs)
SMSs, including vortioxetine and vilazodone, modulate serotonin receptors and inhibit serotonin reuptake. These drugs offer a unique mechanism of action and are used in cases where traditional SSRIs and SNRIs are not effective .
Serotonin Antagonists and Reuptake Inhibitors (SARIs)
SARIs, such as trazodone, work by antagonizing serotonin receptors and inhibiting serotonin reuptake. They are often used for their sedative properties, making them useful in patients with insomnia .
Noradrenergic and Specific Serotonergic Antidepressants (NaSSAs)
NaSSAs, like mirtazapine, enhance the release of norepinephrine and serotonin by blocking alpha-2 adrenergic receptors. They are known for their sedative effects and are often used in patients with significant anxiety or insomnia .
Norepinephrine Reuptake Inhibitors (NRIs)
NRIs, such as reboxetine, selectively inhibit the reuptake of norepinephrine. They are less commonly used but can be effective in patients who do not respond to other types of antidepressants .
Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)
NDRIs, like bupropion, inhibit the reuptake of norepinephrine and dopamine. They are often used in patients who experience sexual side effects from SSRIs or SNRIs, as they have a lower incidence of these side effects Protti2020Stahl1998.
Melatonergic Agonists and Selective Serotonergic Antagonists (MaSSAs)
MaSSAs, such as agomelatine, act on melatonin receptors and serotonin receptors. They are used for their unique mechanism of action and favorable side effect profile .
Emerging Antidepressants
Anti-Inflammatory Drugs
Recent studies have shown that anti-inflammatory drugs, including NSAIDs and cytokine inhibitors, can have antidepressant effects. These drugs are being explored as potential treatments for depression, especially in patients with inflammation-related depressive symptoms .
Ketamine
Ketamine, an NMDA receptor antagonist, has shown rapid antidepressant effects in treatment-resistant depression. It represents a significant advancement in the treatment of depression, offering new hope for patients who do not respond to traditional antidepressants .
Conclusion
Antidepressants come in various classes, each with distinct mechanisms of action, efficacy, and side effect profiles. While SSRIs remain the most commonly prescribed, new-generation antidepressants and emerging treatments like ketamine and anti-inflammatory drugs offer additional options for patients. Understanding the differences among these medications can help tailor treatment to individual patient needs, improving outcomes and minimizing side effects.
Sources and full results
Most relevant research papers on this topic